Elevated levels of tumor necrosis factor-α in zairian neonate plasmas: Implications for perinatal infection with the human immunodeficiency virus

Journal of Infectious Diseases

Volumn 169, Issue 5, 1994, Pages 975-980

  Brown, Christopher C ^a,b,c,d,e   Poli, Guido ^a,b,c,d   Lubaki, Ndongala ^a,b,c,d   St Louis, Michael ^a,b,c,d   Davachi, Farzin ^a,b,c,d   Musey, Luwy ^a,b,c,d   Manzila, Tarande ^a,b,c,d   Kovacs, Andrea ^a,b,c,d   Quinn, Thomas C ^a,b,c,d   Fauci, Anthony S ^a,b,c,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Mama Yemo Hospital ^*  (Democratic Republic Congo)

^e Sheridan ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DEMOCRATIC REPUBLIC CONGO; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INFECTION; PERINATAL INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION;

ADULT; CELL LINE; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HIV INFECTIONS; HIV-1; HUMAN; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TUMOR NECROSIS FACTOR; UP-REGULATION; VIRUS REPLICATION;

EID: 0028070276     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.5.975     Document Type: Article

References (36)

1. Blanche S, Rouzioux C, Moscato ML, et al, A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989:320:1643-8.
2. Ryder RW, Nsa W, Hassig SE, et al. Perinatal transmission of the human immunodeficiency virus type 1 to infants of seropositive women in Zaire. N Engl J Med 1989;320:1637-42.
3. Scott GB, Hutto C, Makuch RW, et al. Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med 1989;321:1791-6.
4. European Collaborative Study. Children born to women with HIV-1 infection: Natural history and risk of transmission. Lancet 1991; 337:253-60.
5. Tovo PA, De Martino M, Gabiano C, et al. Prognostic factors and survival in children with perinatal H1V-I infection. Lancet 1992; 339:1249-53.
6. Bacchetti P, Moss AR. Incubation period of AIDS in San Francisco. Nature 1989;338:251-3.
7. Longini IM, Clark WS, Byers RH, et al. Statistical analysis of the stages of HIV infection usinga Markov model. Stal Med 1989;8:831-43.
8. Bernstein LJ, Ochs HD, Wedgewood RJ, Rubinstein A. Defective humoral immunity in pediatric acquired immune deficiency syndrome. J Pediatr 1985;107:352-7.
9. Pahwa R, Good RA, Pahwa S. Prematurity, hypogammaglobulinemia, and neuropathology with human immunodeficiency virus (HIV) infection. Proc Natl Acad Sci USA 1987;84:3826-30.
10. Scott GB. HIV infection in children: Clinical features and management. J Acquir Immune Defic Syndr 1991:4:109-15.
11. Folks TM, Justement J, Kjnter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 1987;238:800-2.
12. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-8.
13. Poli G, Fauci A. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS 1992;8:191-7.
14. Poli G, Kinter A, Justement JS, et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immu nodeficiency virus expression. Proc Natl Acad Sci USA 1990;87: 782-5.
15. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990; 144:480-4.
16. Fauci AS. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991; 114:678-93.
17. Lahdevirta J, Maury CPJ, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:289-91.
18. Von Sydow M, Sonnerborg A, Gaines H, Strannegard O. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages ofHIV-1 infection. AIDS Res Hum Retroviruses 1991:7:375-80.
19. Arditi M, Rabat W, Yogev R. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children. Pediatr Infect Dis J 1991;10:450-5.
20. Gallo P, Laverda AM, Rossi AD, et al. Immunological markers in the cerebrospinal fluid of HIV-1-infected children. Acta Paediatr Scand 1991;80:659-66.
21. Rautonen J, Rautonen N, Martin NL, Philip R, Wara DW. Seruminterleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS 1991;5:1319-25.
22. Folks TM, Justement J, Kinter A, et al. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phor-bol-12-myristate acetate. J Immunol 1988; 140:1 117-22.
23. Willey RL, Smith DH, Laskey LA, et al. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J Virol 1988;62:139-47.
24. Fernie BF, Poli G, Fauci AS. Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells. J Virol 1991;65:3968-71.
25. Rieckmann P, Poli G, Fox CH, Kehrl JH, Fauci AS. Recombinant gp 120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 1991;147:2922-7.
26. Rieckmann P, Poli G, Kehrl JH, Fauci AS. Activated B-lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T-cells and a promonocytic cell line, U-l. J Exp Med 1991;173:1-5.
27. Hoeprich PD. Host-parasite relationships and the pathogenesis of in fectious diseases. In: Hoeprich PD, Jordan MC, eds. Infectious diseases. 4th ed. Philadelphia: Lippincott, 1989:41-53.
28. Sarff LD, McCracken GH, Schiffer MS. et al. Epidemiology of Esche richia coh Kl in healthy and diseased newborns. Lancet 1975; 1:1099-107.
29. Girardin GP, Berner ME, Grau GE, Suter S, Lacourt G, Paunier L. Serum tumor necrosis factor in newborns at risk for infections. Eur J Pediatr 1990;149:645-7.
30. Matsuzaki N, Saji F, Kameda T, et al. In vitro and in vivo production of interleukin-6 by fetal mononuclear cells. Clin Immunol Immuno-pathol 1990;55:305-14.
31. Miller LC, Isa S, LoPreste G, Schaller JG, Dinarello CA. Neonatal interleukin-1 beta, inter!eukin-6. and tumor necrosis factor cord blood levels and cellular production. J Pediatr 1990; 117:961-5.
32. Saito S, Saito M, Kato Y, Maruyama M, Moriyama I, Ichijo M. Production of IL-6 (BSF-2/IFN beta 2) by mononuclear cells in premature and term infants. J Reprod Immunol 1990;17:17-26.
33. Watson W, Oen K, Ramdahin R, Harman C. Immunoglobulin and cytokine production by neonatal lymphocytes. Clin Exp Immunol 1991;83:169-74.
34. Weatherstone KB, Rich EA. Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr Res 1989;25:342-6.
35. Yachie A, Takano N, Yokoi T, et al. The capability of neonatal leukocytes to produce IL-6 on stimulation assessed by whole blood culture. Pediatr Res 1990;27:227-33.
36. Holland S, Colebunders R, Francis H, et al. Tumor necrosis factor in the plasma of Africans infected with HIV [abstract]. In: Program and abstracts: V International Conference on AIDS (Montreal). Ottawa: International Development Research Centre. 1989.